@article{Hernandez_Santiago_V-2023_142182,
title = {Intranasal steroid use and COVID-19 mortality among patients with asthma and COPD: A retrospective cohort study},
author = {Hernandez Santiago, V. and Fagbamigbe, A. and Sullivan, F. and Agrawal, U. and Morales, D. and McCowan, C. and Lipworth, B.},
month = {jul},
year = {2023},
abstract = {Background: Systemic corticosteroids have been widely used for treating patients with severe acute respiratory distress syndrome. Inhaled corticosteroids may have a protective effect for treating acute coronavirus disease 2019 (COVID-19); however, little is known about the potential effect of intranasal corticosteroids (INCS) on COVID-19 outcomes and severity.},
journal = {Annals of Allergy, Asthma and Immunology},
publisher = {Elsevier},
url = {https://doi.org/10.1016/j.anai.2023.06.026},
}
